Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 16 entries
Sorted by: Best Match Show Resources per page
Patents and literature.

Applied biochemistry and biotechnology

Kit M, Narasimhan MJ, Anderson JA, Zimmermann U, Pilwat G, Furuya T, Tani Y, Kolehmainen SE, Tarkkanen V, Barrett SP, Gestrelius SM, Belloc A, Florent J, Lunel J, Palla J, Mancy D, Bailey JE, Cho YK, Mouri T, Kayama H, Foley SE, Oriel PJ, Epstein CC, Kimura K, Spraker PW, Ljungdahl LG, Wieget JK, Levine DW, Thilly WG, Wang DI, Wong JS, Eisinger MG, Young FE, Wilson GA, Mottice SL, Green H, Kehinde O, Buhler M, Olofsson M, Osseux PF, Degen L, Branduzzi P, Olivieri R, Cimini N, Kang KS, Veeder GT, Latymer Z, Andersen G, Drobot W, Monsheimer R, Pfleiderer E, Hidaka H, Kohno T, Eida T, Weisrock WP, Stevens VC, Takezawa K, Hiratani H, Wandrey C, Wichmann R, Leuchtenberger W, Kula M, Buckmann A, Troller J, Koshugi J, Frommer W, Muller L, Schmidt D, Puls W, Krause H, Heber U, Cohen SN, Wahl GM, Stark GR, Collins J, Hohn B, Sugano H, Matsui Y.
PMID: 24234232
Appl Biochem Biotechnol. 1982 May;7(3):217-30. doi: 10.1007/BF02798299.

No abstract available.

Cite
Kit M, Narasimhan MJ, Anderson JA, et al. Patents and literature. Appl Biochem Biotechnol. 1982;7(3):217-30doi: 10.1007/BF02798299.
Kit, M., Narasimhan, M. J., Anderson, J. A., Zimmermann, U., Pilwat, G., Furuya, T., Tani, Y., Kolehmainen, S. E., Tarkkanen, V., Barrett, S. P., Gestrelius, S. M., Belloc, A., Florent, J., Lunel, J., Palla, J., Mancy, D., Bailey, J. E., Cho, Y. K., Mouri, T., Kayama, H., Foley, S. E., Oriel, P. J., Epstein, C. C., Kimura, K., Spraker, P. W., Ljungdahl, L. G., Wieget, J. K., Levine, D. W., Thilly, W. G., Wang, D. I., Wong, J. S., Eisinger, M. G., Young, F. E., Wilson, G. A., Mottice, S. L., Green, H., Kehinde, O., Buhler, M., Olofsson, M., Osseux, P. F., Degen, L., Branduzzi, P., Olivieri, R., Cimini, N., Kang, K. S., Veeder, G. T., Latymer, Z., Andersen, G., Drobot, W., Monsheimer, R., Pfleiderer, E., Hidaka, H., Kohno, T., Eida, T., Weisrock, W. P., Stevens, V. C., Takezawa, K., Hiratani, H., Wandrey, C., Wichmann, R., Leuchtenberger, W., Kula, M., Buckmann, A., Troller, J., Koshugi, J., Frommer, W., Muller, L., Schmidt, D., Puls, W., Krause, H., Heber, U., Cohen, S. N., Wahl, G. M., Stark, G. R., Collins, J., Hohn, B., Sugano, H., & Matsui, Y. (1982). Patents and literature. Applied biochemistry and biotechnology, 7(3), 217-30. https://doi.org/10.1007/BF02798299
Kit, M, et al. "Patents and literature." Applied biochemistry and biotechnology vol. 7,3 (1982): 217-30. doi: https://doi.org/10.1007/BF02798299
Kit M, Narasimhan MJ, Anderson JA, Zimmermann U, Pilwat G, Furuya T, Tani Y, Kolehmainen SE, Tarkkanen V, Barrett SP, Gestrelius SM, Belloc A, Florent J, Lunel J, Palla J, Mancy D, Bailey JE, Cho YK, Mouri T, Kayama H, Foley SE, Oriel PJ, Epstein CC, Kimura K, Spraker PW, Ljungdahl LG, Wieget JK, Levine DW, Thilly WG, Wang DI, Wong JS, Eisinger MG, Young FE, Wilson GA, Mottice SL, Green H, Kehinde O, Buhler M, Olofsson M, Osseux PF, Degen L, Branduzzi P, Olivieri R, Cimini N, Kang KS, Veeder GT, Latymer Z, Andersen G, Drobot W, Monsheimer R, Pfleiderer E, Hidaka H, Kohno T, Eida T, Weisrock WP, Stevens VC, Takezawa K, Hiratani H, Wandrey C, Wichmann R, Leuchtenberger W, Kula M, Buckmann A, Troller J, Koshugi J, Frommer W, Muller L, Schmidt D, Puls W, Krause H, Heber U, Cohen SN, Wahl GM, Stark GR, Collins J, Hohn B, Sugano H, Matsui Y. Patents and literature. Appl Biochem Biotechnol. 1982 May;7(3):217-30. doi: 10.1007/BF02798299. PMID: 24234232.
Copy Download .nbib Format: NLM
Heparan sulfate proteoglycan-dependent neutrophil chemotaxis toward PR-39 cathelicidin.

Journal of inflammation (London, England)

Djanani A, Mosheimer B, Kaneider NC, Ross CR, Ricevuti G, Patsch JR, Wiedermann CJ.
PMID: 17081280
J Inflamm (Lond). 2006 Nov 02;3:14. doi: 10.1186/1476-9255-3-14.

Cathelicidins are mammalian proteins containing a C-terminal cationic antimicrobial domain. Porcine PR-39 cathelicidin affects leukocyte biology. Mechanisms of action may involve alteration of heparan sulfate proteoglycan-dependent functions in inflammatory cells. It was tested whether PR-39 affects human neutrophil migration...

Cite
Djanani A, Mosheimer B, Kaneider NC, et al. Heparan sulfate proteoglycan-dependent neutrophil chemotaxis toward PR-39 cathelicidin. J Inflamm (Lond). 2006;3:14doi: 10.1186/1476-9255-3-14.
Djanani, A., Mosheimer, B., Kaneider, N. C., Ross, C. R., Ricevuti, G., Patsch, J. R., & Wiedermann, C. J. (2006). Heparan sulfate proteoglycan-dependent neutrophil chemotaxis toward PR-39 cathelicidin. Journal of inflammation (London, England), 314. https://doi.org/10.1186/1476-9255-3-14
Djanani, Angela, et al. "Heparan sulfate proteoglycan-dependent neutrophil chemotaxis toward PR-39 cathelicidin." Journal of inflammation (London, England) vol. 3 (2006): 14. doi: https://doi.org/10.1186/1476-9255-3-14
Djanani A, Mosheimer B, Kaneider NC, Ross CR, Ricevuti G, Patsch JR, Wiedermann CJ. Heparan sulfate proteoglycan-dependent neutrophil chemotaxis toward PR-39 cathelicidin. J Inflamm (Lond). 2006 Nov 02;3:14. doi: 10.1186/1476-9255-3-14. PMID: 17081280; PMCID: PMC1635031.
Copy Download .nbib Format: NLM
Enhancement of fibrinogen-triggered pro-coagulant activation of monocytes in vitro by matrix metalloproteinase-9.

Thrombosis journal

Kaneider NC, Mosheimer B, Günther A, Feistritzer C, Wiedermann CJ.
PMID: 20181055
Thromb J. 2010 Jan 29;8(1):2. doi: 10.1186/1477-9560-8-2.

BACKGROUND: Interaction of fibrinogen with specific leukocyte integrins of monocytes may link coagulation and inflammation, however, the precise mechanism of fibrinogen leading to the pro-inflammatory and pro-coagulatory response on monocytes is yet unknown.RESULTS: Fibrinogen and its digestion fragment D...

Cite
Kaneider NC, Mosheimer B, Günther A, et al. Enhancement of fibrinogen-triggered pro-coagulant activation of monocytes in vitro by matrix metalloproteinase-9. Thromb J. 2010;8(1):2doi: 10.1186/1477-9560-8-2.
Kaneider, N. C., Mosheimer, B., Günther, A., Feistritzer, C., & Wiedermann, C. J. (2010). Enhancement of fibrinogen-triggered pro-coagulant activation of monocytes in vitro by matrix metalloproteinase-9. Thrombosis journal, 8(1), 2. https://doi.org/10.1186/1477-9560-8-2
Kaneider, Nicole C, et al. "Enhancement of fibrinogen-triggered pro-coagulant activation of monocytes in vitro by matrix metalloproteinase-9." Thrombosis journal vol. 8,1 (2010): 2. doi: https://doi.org/10.1186/1477-9560-8-2
Kaneider NC, Mosheimer B, Günther A, Feistritzer C, Wiedermann CJ. Enhancement of fibrinogen-triggered pro-coagulant activation of monocytes in vitro by matrix metalloproteinase-9. Thromb J. 2010 Jan 29;8(1):2. doi: 10.1186/1477-9560-8-2. PMID: 20181055; PMCID: PMC2837620.
Copy Download .nbib Format: NLM
Natural Killer Cells from Patients with Recombinase-Activating Gene and Non-Homologous End Joining Gene Defects Comprise a Higher Frequency of CD56.

Frontiers in immunology

Dobbs K, Tabellini G, Calzoni E, Patrizi O, Martinez P, Giliani SC, Moratto D, Al-Herz W, Cancrini C, Cowan M, Bleesing J, Booth C, Buchbinder D, Burns SO, Chatila TA, Chou J, Daza-Cajigal V, Ott de Bruin LM, de la Morena M, Di Matteo G, Finocchi A, Geha R, Goyal RK, Hayward A, Holland S, Huang CH, Kanariou MG, King A, Kaplan B, Kleva A, Kuijpers TW, Lee BW, Lougaris V, Massaad M, Meyts I, Morsheimer M, Neven B, Pai SY, Parvaneh N, Plebani A, Prockop S, Reisli I, Soh JY, Somech R, Torgerson TR, Kim YJ, Walter JE, Gennery AR, Keles S, Manis JP, Marcenaro E, Moretta A, Parolini S, Notarangelo LD.
PMID: 28769923
Front Immunol. 2017 Jul 17;8:798. doi: 10.3389/fimmu.2017.00798. eCollection 2017.

Mutations of the recombinase-activating genes 1 and 2 (

Cite
Dobbs K, Tabellini G, Calzoni E, et al. Natural Killer Cells from Patients with Recombinase-Activating Gene and Non-Homologous End Joining Gene Defects Comprise a Higher Frequency of CD56. Front Immunol. 2017;8:798doi: 10.3389/fimmu.2017.00798.
Dobbs, K., Tabellini, G., Calzoni, E., Patrizi, O., Martinez, P., Giliani, S. C., Moratto, D., Al-Herz, W., Cancrini, C., Cowan, M., Bleesing, J., Booth, C., Buchbinder, D., Burns, S. O., Chatila, T. A., Chou, J., Daza-Cajigal, V., Ott de Bruin, L. M., de la Morena, M., Di Matteo, G., Finocchi, A., Geha, R., Goyal, R. K., Hayward, A., Holland, S., Huang, C. H., Kanariou, M. G., King, A., Kaplan, B., Kleva, A., Kuijpers, T. W., Lee, B. W., Lougaris, V., Massaad, M., Meyts, I., Morsheimer, M., Neven, B., Pai, S. Y., Parvaneh, N., Plebani, A., Prockop, S., Reisli, I., Soh, J. Y., Somech, R., Torgerson, T. R., Kim, Y. J., Walter, J. E., Gennery, A. R., Keles, S., Manis, J. P., Marcenaro, E., Moretta, A., Parolini, S., & Notarangelo, L. D. (2017). Natural Killer Cells from Patients with Recombinase-Activating Gene and Non-Homologous End Joining Gene Defects Comprise a Higher Frequency of CD56. Frontiers in immunology, 8798. https://doi.org/10.3389/fimmu.2017.00798
Dobbs, Kerry, et al. "Natural Killer Cells from Patients with Recombinase-Activating Gene and Non-Homologous End Joining Gene Defects Comprise a Higher Frequency of CD56." Frontiers in immunology vol. 8 (2017): 798. doi: https://doi.org/10.3389/fimmu.2017.00798
Dobbs K, Tabellini G, Calzoni E, Patrizi O, Martinez P, Giliani SC, Moratto D, Al-Herz W, Cancrini C, Cowan M, Bleesing J, Booth C, Buchbinder D, Burns SO, Chatila TA, Chou J, Daza-Cajigal V, Ott de Bruin LM, de la Morena M, Di Matteo G, Finocchi A, Geha R, Goyal RK, Hayward A, Holland S, Huang CH, Kanariou MG, King A, Kaplan B, Kleva A, Kuijpers TW, Lee BW, Lougaris V, Massaad M, Meyts I, Morsheimer M, Neven B, Pai SY, Parvaneh N, Plebani A, Prockop S, Reisli I, Soh JY, Somech R, Torgerson TR, Kim YJ, Walter JE, Gennery AR, Keles S, Manis JP, Marcenaro E, Moretta A, Parolini S, Notarangelo LD. Natural Killer Cells from Patients with Recombinase-Activating Gene and Non-Homologous End Joining Gene Defects Comprise a Higher Frequency of CD56. Front Immunol. 2017 Jul 17;8:798. doi: 10.3389/fimmu.2017.00798. eCollection 2017. PMID: 28769923; PMCID: PMC5511964.
Copy Download .nbib Format: NLM
Nonhealing Right Lower Leg Ulcer: Challenge.

The American Journal of dermatopathology

Blue E, Abbott J, Laggis C, Duffy K, Sontheimer R, Klein S.
PMID: 31592863
Am J Dermatopathol. 2021 Jan 01;43(1):e3-e4. doi: 10.1097/DAD.0000000000001538.

No abstract available.

Cite
Blue E, Abbott J, Laggis C, et al. Nonhealing Right Lower Leg Ulcer: Challenge. Am J Dermatopathol. 2021;43(1):e3-e4doi: 10.1097/DAD.0000000000001538.
Blue, E., Abbott, J., Laggis, C., Duffy, K., Sontheimer, R., & Klein, S. (2021). Nonhealing Right Lower Leg Ulcer: Challenge. The American Journal of dermatopathology, 43(1), e3-e4. https://doi.org/10.1097/DAD.0000000000001538
Blue, Elliot, et al. "Nonhealing Right Lower Leg Ulcer: Challenge." The American Journal of dermatopathology vol. 43,1 (2021): e3-e4. doi: https://doi.org/10.1097/DAD.0000000000001538
Blue E, Abbott J, Laggis C, Duffy K, Sontheimer R, Klein S. Nonhealing Right Lower Leg Ulcer: Challenge. Am J Dermatopathol. 2021 Jan 01;43(1):e3-e4. doi: 10.1097/DAD.0000000000001538. PMID: 31592863.
Copy Download .nbib Format: NLM
Switching and Discontinuation Patterns Among Patients Stable on Originator Infliximab Who Switched to an Infliximab Biosimilar or Remained on Originator Infliximab.

Biologics : targets & therapy

Fitzgerald T, Melsheimer R, Lafeuille MH, Lefebvre P, Morrison L, Woodruff K, Lin I, Emond B.
PMID: 33442230
Biologics. 2021 Jan 06;15:1-15. doi: 10.2147/BTT.S285610. eCollection 2021.

OBJECTIVE: To compare switching and discontinuation patterns of patients stable on originator infliximab (IFX) who switched to an IFX biosimilar (switchers) or remained on originator IFX (continuers) in the United States.METHODS: Symphony Health Solutions' Patient Transactional Datasets (10/2012-03/2019) were...

Cite
Fitzgerald T, Melsheimer R, Lafeuille MH, et al. Switching and Discontinuation Patterns Among Patients Stable on Originator Infliximab Who Switched to an Infliximab Biosimilar or Remained on Originator Infliximab. Biologics. 2021;15:1-15doi: 10.2147/BTT.S285610.
Fitzgerald, T., Melsheimer, R., Lafeuille, M. H., Lefebvre, P., Morrison, L., Woodruff, K., Lin, I., & Emond, B. (2021). Switching and Discontinuation Patterns Among Patients Stable on Originator Infliximab Who Switched to an Infliximab Biosimilar or Remained on Originator Infliximab. Biologics : targets & therapy, 151-15. https://doi.org/10.2147/BTT.S285610
Fitzgerald, Timothy, et al. "Switching and Discontinuation Patterns Among Patients Stable on Originator Infliximab Who Switched to an Infliximab Biosimilar or Remained on Originator Infliximab." Biologics : targets & therapy vol. 15 (2021): 1-15. doi: https://doi.org/10.2147/BTT.S285610
Fitzgerald T, Melsheimer R, Lafeuille MH, Lefebvre P, Morrison L, Woodruff K, Lin I, Emond B. Switching and Discontinuation Patterns Among Patients Stable on Originator Infliximab Who Switched to an Infliximab Biosimilar or Remained on Originator Infliximab. Biologics. 2021 Jan 06;15:1-15. doi: 10.2147/BTT.S285610. eCollection 2021. PMID: 33442230; PMCID: PMC7797299.
Copy Download .nbib Format: NLM
Concurrence of erythema elevatum diutinum and HIV infection: A case report and literature review.

JAAD case reports

Logan S, Sontheimer R.
PMID: 31828194
JAAD Case Rep. 2019 Nov 26;5(12):1093-1096. doi: 10.1016/j.jdcr.2019.10.011. eCollection 2019 Dec.

No abstract available.

Cite
Logan S, Sontheimer R. Concurrence of erythema elevatum diutinum and HIV infection: A case report and literature review. JAAD Case Rep. 2019;5(12):1093-1096doi: 10.1016/j.jdcr.2019.10.011.
Logan, S., & Sontheimer, R. (2019). Concurrence of erythema elevatum diutinum and HIV infection: A case report and literature review. JAAD case reports, 5(12), 1093-1096. https://doi.org/10.1016/j.jdcr.2019.10.011
Logan, Sam, and Sontheimer, Richard. "Concurrence of erythema elevatum diutinum and HIV infection: A case report and literature review." JAAD case reports vol. 5,12 (2019): 1093-1096. doi: https://doi.org/10.1016/j.jdcr.2019.10.011
Logan S, Sontheimer R. Concurrence of erythema elevatum diutinum and HIV infection: A case report and literature review. JAAD Case Rep. 2019 Nov 26;5(12):1093-1096. doi: 10.1016/j.jdcr.2019.10.011. eCollection 2019 Dec. PMID: 31828194; PMCID: PMC6889235.
Copy Download .nbib Format: NLM
Patents and literature.

Applied biochemistry and biotechnology

Rembaum A, Rohrbach RP, Klose S, Batz HG, Stoltz M, Hagen A, Weimann G, Wildman SG, Kwanyuen P, Franzmann G, Wulsmann HL, Nakanishi T, Shigemasa Y, Monsheimer R, Pfleiderer E, Yoshioka T, Teramoto K, Shimamura M, Lee CK, Tamuri M, Kanno M, Ishi Y, Kaetsu I, Kumakura M, Yoshida M, Strobel GA, Johnson DE, Srinivasan VR, Choi YC, Fukuda H, Shiotani T, Okada W, Messing RA, Oppermann RA, Simpson LB, Takeguchi MM, Bigazzi M, Higerd TB, Goust JM, Tolbert WR, Kuo MJ, Feder J, Patel RN, Hou CT, Laskin AI, Yukawa H, Osumi K, Takayama Y, Fujiwara A, Masuda S, Takaku F, Ogasa K, Kuboyama M, Saito M, Yanai N, Nishida M, Tosaka O, Ono E, Ishihara M, Morioka H, Takinami K, Taoka A, Uchida S, Puls J, Sinner M, Dietrichs HH, Wicklow DT, Detroy RW, Heady RE, Yukawa H, Osumi K, Nara T, Takayama Y, Knight E, Tsao GT, Ladisch MR, Ladisch CM, Hsu TA, Friesen HJ, Pestka S, Manis JJ, Debabov VG, Kozlov JI, Zhdanova NI, Khurges EM, Yankovsky NK, Rozinov MR, Shakulov RS, Rebentish BA, Livshits VA, Gusyatiner MM, Mashko SV, Moshentseva VN, Kozyreva LF, Arsatiants RA, Goodman HM, Shine J, Horst P, Goeddel DV, Heyneker HL.
PMID: 24233981
Appl Biochem Biotechnol. 1981 Dec;6(4):339-51. doi: 10.1007/BF02798284.

No abstract available.

Cite
Rembaum A, Rohrbach RP, Klose S, et al. Patents and literature. Appl Biochem Biotechnol. 1981;6(4):339-51doi: 10.1007/BF02798284.
Rembaum, A., Rohrbach, R. P., Klose, S., Batz, H. G., Stoltz, M., Hagen, A., Weimann, G., Wildman, S. G., Kwanyuen, P., Franzmann, G., Wulsmann, H. L., Nakanishi, T., Shigemasa, Y., Monsheimer, R., Pfleiderer, E., Yoshioka, T., Teramoto, K., Shimamura, M., Lee, C. K., Tamuri, M., Kanno, M., Ishi, Y., Kaetsu, I., Kumakura, M., Yoshida, M., Strobel, G. A., Johnson, D. E., Srinivasan, V. R., Choi, Y. C., Fukuda, H., Shiotani, T., Okada, W., Messing, R. A., Oppermann, R. A., Simpson, L. B., Takeguchi, M. M., Bigazzi, M., Higerd, T. B., Goust, J. M., Tolbert, W. R., Kuo, M. J., Feder, J., Patel, R. N., Hou, C. T., Laskin, A. I., Yukawa, H., Osumi, K., Takayama, Y., Fujiwara, A., Masuda, S., Takaku, F., Ogasa, K., Kuboyama, M., Saito, M., Yanai, N., Nishida, M., Tosaka, O., Ono, E., Ishihara, M., Morioka, H., Takinami, K., Taoka, A., Uchida, S., Puls, J., Sinner, M., Dietrichs, H. H., Wicklow, D. T., Detroy, R. W., Heady, R. E., Yukawa, H., Osumi, K., Nara, T., Takayama, Y., Knight, E., Tsao, G. T., Ladisch, M. R., Ladisch, C. M., Hsu, T. A., Friesen, H. J., Pestka, S., Manis, J. J., Debabov, V. G., Kozlov, J. I., Zhdanova, N. I., Khurges, E. M., Yankovsky, N. K., Rozinov, M. R., Shakulov, R. S., Rebentish, B. A., Livshits, V. A., Gusyatiner, M. M., Mashko, S. V., Moshentseva, V. N., Kozyreva, L. F., Arsatiants, R. A., Goodman, H. M., Shine, J., Horst, P., Goeddel, D. V., & Heyneker, H. L. (1981). Patents and literature. Applied biochemistry and biotechnology, 6(4), 339-51. https://doi.org/10.1007/BF02798284
Rembaum, A, et al. "Patents and literature." Applied biochemistry and biotechnology vol. 6,4 (1981): 339-51. doi: https://doi.org/10.1007/BF02798284
Rembaum A, Rohrbach RP, Klose S, Batz HG, Stoltz M, Hagen A, Weimann G, Wildman SG, Kwanyuen P, Franzmann G, Wulsmann HL, Nakanishi T, Shigemasa Y, Monsheimer R, Pfleiderer E, Yoshioka T, Teramoto K, Shimamura M, Lee CK, Tamuri M, Kanno M, Ishi Y, Kaetsu I, Kumakura M, Yoshida M, Strobel GA, Johnson DE, Srinivasan VR, Choi YC, Fukuda H, Shiotani T, Okada W, Messing RA, Oppermann RA, Simpson LB, Takeguchi MM, Bigazzi M, Higerd TB, Goust JM, Tolbert WR, Kuo MJ, Feder J, Patel RN, Hou CT, Laskin AI, Yukawa H, Osumi K, Takayama Y, Fujiwara A, Masuda S, Takaku F, Ogasa K, Kuboyama M, Saito M, Yanai N, Nishida M, Tosaka O, Ono E, Ishihara M, Morioka H, Takinami K, Taoka A, Uchida S, Puls J, Sinner M, Dietrichs HH, Wicklow DT, Detroy RW, Heady RE, Yukawa H, Osumi K, Nara T, Takayama Y, Knight E, Tsao GT, Ladisch MR, Ladisch CM, Hsu TA, Friesen HJ, Pestka S, Manis JJ, Debabov VG, Kozlov JI, Zhdanova NI, Khurges EM, Yankovsky NK, Rozinov MR, Shakulov RS, Rebentish BA, Livshits VA, Gusyatiner MM, Mashko SV, Moshentseva VN, Kozyreva LF, Arsatiants RA, Goodman HM, Shine J, Horst P, Goeddel DV, Heyneker HL. Patents and literature. Appl Biochem Biotechnol. 1981 Dec;6(4):339-51. doi: 10.1007/BF02798284. PMID: 24233981.
Copy Download .nbib Format: NLM
Corrigendum: Natural Killer Cells from Patients with Recombinase-Activating Gene and Non-Homologous End Joining Gene Defects Comprise a Higher Frequency of CD56.

Frontiers in immunology

Dobbs K, Tabellini G, Calzoni E, Patrizi O, Martinez P, Giliani SC, Moratto D, Al-Herz W, Cancrini C, Cowan M, Bleesing J, Booth C, Buchbinder D, Burns SO, Chatila TA, Chou J, Daza-Cajigal V, Ott de Bruin LM, de la Morena MT, Di Matteo G, Finocchi A, Geha R, Goyal RK, Hayward A, Holland S, Huang CH, Kanariou MG, King A, Kaplan B, Kleva A, Kuijpers TW, Lee BW, Lougaris V, Massaad M, Meyts I, Morsheimer M, Neven B, Pai SY, Parvaneh N, Plebani A, Prockop S, Reisli I, Soh JY, Somech R, Torgerson TR, Kim YJ, Walter JE, Gennery AR, Keles S, Manis JP, Marcenaro E, Moretta A, Parolini S, Notarangelo LD.
PMID: 29042861
Front Immunol. 2017 Oct 10;8:1244. doi: 10.3389/fimmu.2017.01244. eCollection 2017.

[This corrects the article on p. 798 in vol. 8, PMID: 28769923.].

Cite
Dobbs K, Tabellini G, Calzoni E, et al. Corrigendum: Natural Killer Cells from Patients with Recombinase-Activating Gene and Non-Homologous End Joining Gene Defects Comprise a Higher Frequency of CD56. Front Immunol. 2017;8:1244doi: 10.3389/fimmu.2017.01244.
Dobbs, K., Tabellini, G., Calzoni, E., Patrizi, O., Martinez, P., Giliani, S. C., Moratto, D., Al-Herz, W., Cancrini, C., Cowan, M., Bleesing, J., Booth, C., Buchbinder, D., Burns, S. O., Chatila, T. A., Chou, J., Daza-Cajigal, V., Ott de Bruin, L. M., de la Morena, M. T., Di Matteo, G., Finocchi, A., Geha, R., Goyal, R. K., Hayward, A., Holland, S., Huang, C. H., Kanariou, M. G., King, A., Kaplan, B., Kleva, A., Kuijpers, T. W., Lee, B. W., Lougaris, V., Massaad, M., Meyts, I., Morsheimer, M., Neven, B., Pai, S. Y., Parvaneh, N., Plebani, A., Prockop, S., Reisli, I., Soh, J. Y., Somech, R., Torgerson, T. R., Kim, Y. J., Walter, J. E., Gennery, A. R., Keles, S., Manis, J. P., Marcenaro, E., Moretta, A., Parolini, S., & Notarangelo, L. D. (2017). Corrigendum: Natural Killer Cells from Patients with Recombinase-Activating Gene and Non-Homologous End Joining Gene Defects Comprise a Higher Frequency of CD56. Frontiers in immunology, 81244. https://doi.org/10.3389/fimmu.2017.01244
Dobbs, Kerry, et al. "Corrigendum: Natural Killer Cells from Patients with Recombinase-Activating Gene and Non-Homologous End Joining Gene Defects Comprise a Higher Frequency of CD56." Frontiers in immunology vol. 8 (2017): 1244. doi: https://doi.org/10.3389/fimmu.2017.01244
Dobbs K, Tabellini G, Calzoni E, Patrizi O, Martinez P, Giliani SC, Moratto D, Al-Herz W, Cancrini C, Cowan M, Bleesing J, Booth C, Buchbinder D, Burns SO, Chatila TA, Chou J, Daza-Cajigal V, Ott de Bruin LM, de la Morena MT, Di Matteo G, Finocchi A, Geha R, Goyal RK, Hayward A, Holland S, Huang CH, Kanariou MG, King A, Kaplan B, Kleva A, Kuijpers TW, Lee BW, Lougaris V, Massaad M, Meyts I, Morsheimer M, Neven B, Pai SY, Parvaneh N, Plebani A, Prockop S, Reisli I, Soh JY, Somech R, Torgerson TR, Kim YJ, Walter JE, Gennery AR, Keles S, Manis JP, Marcenaro E, Moretta A, Parolini S, Notarangelo LD. Corrigendum: Natural Killer Cells from Patients with Recombinase-Activating Gene and Non-Homologous End Joining Gene Defects Comprise a Higher Frequency of CD56. Front Immunol. 2017 Oct 10;8:1244. doi: 10.3389/fimmu.2017.01244. eCollection 2017. PMID: 29042861; PMCID: PMC5641412.
Copy Download .nbib Format: NLM
High Prevalence of Carbapenemase-Producing .

Microorganisms

Monnheimer M, Cooper P, Amegbletor HK, Pellio T, Groß U, Pfeifer Y, Schulze MH.
PMID: 33807838
Microorganisms. 2021 Mar 05;9(3). doi: 10.3390/microorganisms9030537.

Three years after a prospective study on wound infections in a rural hospital in Ghana revealed no emergence of carbapenem-resistant bacteria we initiated a new study to assess the prevalence of multidrug-resistant pathogens. Three hundred and one samples of...

Cite
Monnheimer M, Cooper P, Amegbletor HK, et al. High Prevalence of Carbapenemase-Producing . Microorganisms. 2021;9(3)doi: 10.3390/microorganisms9030537.
Monnheimer, M., Cooper, P., Amegbletor, H. K., Pellio, T., Groß, U., Pfeifer, Y., & Schulze, M. H. (2021). High Prevalence of Carbapenemase-Producing . Microorganisms, 9(3), . https://doi.org/10.3390/microorganisms9030537
Monnheimer, Mathieu, et al. "High Prevalence of Carbapenemase-Producing ." Microorganisms vol. 9,3 (2021). doi: https://doi.org/10.3390/microorganisms9030537
Monnheimer M, Cooper P, Amegbletor HK, Pellio T, Groß U, Pfeifer Y, Schulze MH. High Prevalence of Carbapenemase-Producing . Microorganisms. 2021 Mar 05;9(3). doi: 10.3390/microorganisms9030537. PMID: 33807838; PMCID: PMC7998214.
Copy Download .nbib Format: NLM
ASH Meeting 2016: developments in hemostaseology.

Memo

Feistritzer C, Mosheimer B.
PMID: 28725275
Memo. 2017;10(2):72-75. doi: 10.1007/s12254-017-0339-z. Epub 2017 Jun 01.

During the annual meeting of the American Society of Hematology (ASH) in San Diego/California, novel developments in the field of hemostaseology were presented. Alternative treatment strategies besides factor replacement were discussed for patients with hemophilia. One of the highlights...

Cite
Feistritzer C, Mosheimer B. ASH Meeting 2016: developments in hemostaseology. Memo. 2017;10(2):72-75doi: 10.1007/s12254-017-0339-z.
Feistritzer, C., & Mosheimer, B. (2017). ASH Meeting 2016: developments in hemostaseology. Memo, 10(2), 72-75. https://doi.org/10.1007/s12254-017-0339-z
Feistritzer, Clemens, and Mosheimer, Birgit. "ASH Meeting 2016: developments in hemostaseology." Memo vol. 10,2 (2017): 72-75. doi: https://doi.org/10.1007/s12254-017-0339-z
Feistritzer C, Mosheimer B. ASH Meeting 2016: developments in hemostaseology. Memo. 2017;10(2):72-75. doi: 10.1007/s12254-017-0339-z. Epub 2017 Jun 01. PMID: 28725275; PMCID: PMC5493715.
Copy Download .nbib Format: NLM
Nonhealing Right Lower Leg Ulcer: Answer.

The American Journal of dermatopathology

Blue E, Abbott J, Laggis C, Duffy K, Sontheimer R, Klein S.
PMID: 33337626
Am J Dermatopathol. 2021 Jan 01;43(1):77. doi: 10.1097/DAD.0000000000001537.

No abstract available.

Cite
Blue E, Abbott J, Laggis C, et al. Nonhealing Right Lower Leg Ulcer: Answer. Am J Dermatopathol. 2021;43(1):77doi: 10.1097/DAD.0000000000001537.
Blue, E., Abbott, J., Laggis, C., Duffy, K., Sontheimer, R., & Klein, S. (2021). Nonhealing Right Lower Leg Ulcer: Answer. The American Journal of dermatopathology, 43(1), 77. https://doi.org/10.1097/DAD.0000000000001537
Blue, Elliot, et al. "Nonhealing Right Lower Leg Ulcer: Answer." The American Journal of dermatopathology vol. 43,1 (2021): 77. doi: https://doi.org/10.1097/DAD.0000000000001537
Blue E, Abbott J, Laggis C, Duffy K, Sontheimer R, Klein S. Nonhealing Right Lower Leg Ulcer: Answer. Am J Dermatopathol. 2021 Jan 01;43(1):77. doi: 10.1097/DAD.0000000000001537. PMID: 33337626.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 16 entries